참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Methyltryptamine | HCID 6088 | — |
| 반응물 | N-(3-chloropropyl)piperidine hydrochloride | HCID 79624 | — |
| 반응물 | 1-(3-Chloropropyl)-3-(4-methoxyphenyl)piperidine hydrochloride | HCID 18001209 | — |
| 생성물 | (2-Indol-3-ylethyl)methyl(3-piperidylpropyl)amine Hydrochloride | HCID 70038108 | — |
반응 단계
Using 3-(2-methylaminoethyl)indole (123 mg, 0.70 mmol) and 1-(3-chloropropyl)piperidine hydrochloride (198 mg, 1.0 mmol) instead of 4-(3-indolyl)piperidine and 1-(3-chloropropyl)-3-(4-methoxyphenyl)piperidine hydrochloride respectively, reaction and concentration were carried out in the same procedure as Example 2. The resulting crude product was purified by column chromatography on a silica gel (silica gel NH-DM 1020 produced by Fuji Silysia Chemical Ltd., eluent; hexane:ethyl acetate=1:1) to afford a free form (166 mg) of the title compound as a pale yellow viscous oil. After adding hydrochloric acid/methanol to a solution of the free form in methanol, the mixture was concentrated and was then reprecipitated with methanol/ether to afford the title compound (167 mg, yield: 64%) as a pale yellow crystalline powder.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06642228B1 |
|---|
| 출처 데이터셋 | uspto-grants-2003_11 |
|---|
| ORD ID | ord-56eef1aae78645eda9dc05bd421b5a5b |
|---|
| 출처 메모 | uspto-grants-2003_11 |
|---|